Status:
RECRUITING
A RCT on the Preventive Effect of HFNC on Postoperative Pulmonary Complications in Patients With Gynecologic Neoplasms
Lead Sponsor:
Sichuan Cancer Hospital and Research Institute
Conditions:
Gynecologic Surgery
High-flow Nasal Cannula
Eligibility:
FEMALE
18-90 years
Phase:
NA
Brief Summary
Patients at high risk of post-operative pulmonary complications (PPC) will be screened out from gynecological tumor patients undergoing surgical treatment, and randomly assigned into the HFNC group an...
Detailed Description
This randomized con aims to enroll patients at high risk of developing post-operative pulmonary complications after gynecological surgery, the eligible patients will be randomly assigned to receive ox...
Eligibility Criteria
Inclusion Criteria:
-
Patients with gynecologic Neoplasms, including benign gynecologic tumors and malignant gynecologic tumors, who are 18 to 90 years old and are scheduled for surgical treatment in our center shall receive plain chest CT scan within 1 week before surgery, and the estimated surgical time shall be ≥2 hours, and at least one of the following conditions shall be met:
- Assess respiratory risk in surgical patients in Catalonia (ARRSPC) ≥45 points;
- BMI≥30;
- Moderate to severe asthma;
- Moderate to severe chronic obstructive pulmonary disease (COPD);
- Smoking history ≥20 packs/year
Exclusion Criteria:
- Patients with lung metastasis of malignant tumor or primary lung malignant tumor;
- previous lung surgery or radiotherapy;
- the surgery involved segmental bowel resection.
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05526534
Start Date
November 1 2022
End Date
December 31 2025
Last Update
May 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sichuan Cancer Hospital and Research Institute
Chengdu, Sichuan, China, 610000